Register Cart 0

Generic placeholder image

Current Medicinal Chemistry - Central Nervous System Agents

Editor-in-Chief

ISSN (Print): 1568-0150
ISSN (Online): 1875-6158

Back Subscribe

Preface

Author(s): Gregory S. Hamilton

Volume 3, Issue 1, 2003

Page: [i - i] Pages: 1

DOI: 10.2174/1568015033357814

Price: $65

« Previous

Rights & Permissions Print Cite

Article Metrics

10

Related Articles

The Possible Therapeutic Actions of Peroxisome Proliferator-Activated Receptor α(PPARα) Agonists,PPARγ Agonists,3-Hydroxy-3- Methylglutaryl Coenzyme A (HMG-CoA)Reductase Inhibitors,Angiotensin Converting Enzyme (ACE)Inhibitors and Calcium (Ca)-Antagonists on Vascular Endothelial Cells
Current Drug Targets - Cardiovascular & Hematological Disorders

Phyto-derived Products as Matrix Metalloproteinases Inhibitors in Cardiovascular Diseases
Current Hypertension Reviews

Early Detection of Epileptic Seizures in Sparse Domains
Neuroscience and Biomedical Engineering (Discontinued)

The Role of Type 2 Fibroblast Growth Factor in Periodontal Therapy
Current Drug Targets

Apixaban: Effective and Safe in Preventing Thromboembolic Events in Patients with Atrial Fibrillation and Renal Failure
Current Medicinal Chemistry

KCa3.1 Channels and Glioblastoma: In Vitro Studies
Current Neuropharmacology

Neutrophil Cell Count is Related to Hypertension in Workers: A Cross- Sectional Study
Vascular Disease Prevention (Discontinued)

HDL Elevation and Lipid Lowering Therapy: Current Scenario and Future Perspectives
Recent Patents on Cardiovascular Drug Discovery

Oxidative Stress and Transforming Growth Factor-β<sub>1</sub>-induced Cardiac Fibrosis
Cardiovascular & Hematological Disorders-Drug Targets

Diagnostic and Therapeutic Potentials of microRNAs in Heart Failure
Current Topics in Medicinal Chemistry

GABA Puts a Stop to Pain
Current Drug Targets - CNS & Neurological Disorders

Editorial: Vascular Calcification, Cardiovascular Risk and microRNAs
Current Vascular Pharmacology

subject Index To Volume 1
Current Drug Targets - CNS & Neurological Disorders

Scope of Lipid Nanoparticles in Neuroscience: Impact on the Treatment of Neurodegenerative Diseases
Current Pharmaceutical Design

By Discontinuing Beta-Blockers Before an Exercise Test, We may Precipitate a Rebound Phenomenon
Current Vascular Pharmacology

Advances in Irrigated Tip Catheter Technology for Treatment of Cardiac Arrhythmias
Recent Patents on Cardiovascular Drug Discovery

Nonalcoholic Fatty Liver Disease (NAFLD) for Primary Care Providers: Beyond the Liver
Current Hypertension Reviews

2-Acetylbenzofurans: Synthesis, Reactions and Applications
Current Organic Chemistry

Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Antagonists in Experimental Myocarditis
Current Pharmaceutical Design

Patent Selections:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)

© 2025 Bentham Science Publishers | Privacy Policy